A synthetic peptide fragment of thymosin beta-4, researched for wound healing and tissue repair.
Life science alliance|2019|Renga G et al.
Chronic granulomatous disease (CGD) is a genetic disorder of the NADPH oxidase characterized by increased susceptibility to infections and hyperinflammation associated with defective autophagy and increased inflammasome activation. Herein, we demonst…
Animal Study
PMID: 31719116
Revista espanola de enfermedades digestivas|2019|Jiang Y et al.
BACKGROUND AND AIMS: non-alcoholic fatty liver disease (NAFLD) is the most common type of chronic liver injury worldwide. Some studies have shown that thymosin beta4 (Tβ4) is closely related to liver diseases. Nevertheless, only a few published studi…
PMID: 30896961
Journal of Alzheimer's disease : JAD|2019|Akerman S et al.
There is increasing evidence suggesting that amyloidogenic proteins might form deposits in non-neuronal tissues in neurodegenerative disorders such as Alzheimer's or Parkinson's diseases. However, the detection of these aggregation-prone proteins wit…
PMID: 31006686
Neuroscience research|2019|Wang L et al.
Angiopoietin-1 (Ang1) and its receptor Tie2 regulate vascular function. Our previous study demonstrated that thymosin beta 4 (Tβ4) ameliorates neurological function of diabetic peripheral neuropathy. Mechanisms underlying the therapeutic effect of Tβ…
Animal Study
PMID: 30326249
Cells|2018|Carion T et al.
With increasing multidrug resistance and contraindication for corticosteroid use, the goal of this study was to develop thymosin beta-4 (Tβ4) as an adjunctive therapy to antibiotics for the treatment of bacterial keratitis that effectively promotes e…
PMID: 30241380
BMC research notes|2018|Stark C et al.
OBJECTIVE: We wanted to determine the impact of different doses of a pegylated and liposomal formulation of the cardiotoxic drug doxorubicin on cardiac function, fibrosis and survival in mice. The drug causes myocardial damage by producing reactive o…
Animal Study
PMID: 29467032
Expert opinion on biological therapy|2018|Pardon M
INTRODUCTION: The actin-sequestering thymosin beta4 (Tβ4) is the most abundant member of the β-thymosins, and is widely expressed in the central nervous system (CNS), but its functions in the healthy and diseased brain are poorly understood. The expr…
Review
PMID: 30063850
Expert opinion on biological therapy|2018|Gupta S, Li L
INTRODUCTION: Thymosin beta-4 (Tβ4) is an actin sequestering protein and is furthermore involved in diverse biological processes including cell proliferation, differentiation, wound healing, stem- or progenitor cell differentiation, and modulates inf…
ReviewAnimal Study
PMID: 30063846
Expert opinion on biological therapy|2018|Belsky J et al.
INTRODUCTION: Sepsis is the dysregulated host response to an infection resulting in life-threatening organ damage. Thymosin Beta 4 is an actin binding protein that inhibits the polymerization of G-actin into F-actin and improves mortality when admini…
ReviewAnimal Study
PMID: 29508629
Journal of nanoscience and nanotechnology|2018|Choi B et al.
Thymosin β4 (Tβ4) is known to inhibit an inflammatory response and to increase the survival of osteoblasts on titanium (Ti) surfaces. Ti is the most widely used graft material in dentistry; however, an inflammatory response induced following implant…
PMID: 29448512
Revista espanola de enfermedades digestivas|2018|Jiang Y et al.
OBJECTIVE: The aim of the study was to determine whether serum thymosin beta4 (Tβ4) can be a useful noninvasive biomarker to differentiate between nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver (NAFL). METHODS: The study included 24…
PMID: 29271227
Chemphyschem : a European journal of chemical physics and physical chemistry|2018|Bokor M et al.
Wide-lineH NMR measurements were extended and all results were reinterpreted in a new thermodynamics-based approach to study aqueous solutions of thymosin-β(Tβ), stabilin C-terminal domain (CTD) and their 1:1 complex. The energy distributions of the…
PMID: 29274195
Expert opinion on biological therapy|2018|Vasilopoulou E, Riley P, Long D
INTRODUCTION: There is an urgent need for new treatments for chronic kidney disease (CKD). Thymosin-β4 is a peptide that reduces inflammation and fibrosis and has the potential to restore endothelial and epithelial cell injury, biological processes i…
ReviewAnimal Study
PMID: 29727205
International journal of molecular medicine|2018|Ji H et al.
Cerebral ischemia causes severe brain injury and results in selective neuronal death through programmed cell death mechanisms, including apoptosis and autophagy. Minimizing neuronal injury has been considered a hot topic among clinicians. The present…
PMID: 29328391
International journal of cardiology|2018|Hao Q et al.
BACKGROUND: Thymosin beta 4 (Tβ4) is a 43-amino-acid peptide with protective properties in myocardium injury. Previously, we produced a recombinant human dimeric Tβ4 (DTβ4). Here, the cardioprotective effects of DTβ4 and the molecular mechanisms unde…
Animal StudyIn Vitro
PMID: 29550018
Pharmacological research|2018|Kumar N, Yin C
Cardiovascular diseases (CVDs) represent ∼31% of all global deaths, and hypertension alone accounts for ∼50% of these cases. Inflammation and subsequent fibrosis in heart, kidney and brain are associated with increased morbidity and mortality in CVD…
Review
PMID: 29990624
Expert opinion on biological therapy|2018|Dubé K, Smart N
INTRODUCTION: Formation of the vasculature is a complex process, defects in which can lead to embryonic lethality or disease in later life. Understanding mechanisms of vasculogenesis may facilitate the treatment of developmental defects and may be ex…
Review
PMID: 30063849
Expert opinion on biological therapy|2018|Morris D, Zhang Z, Chopp M
INTRODUCTION: Thymosin β4 (Tβ4) is a 5K peptide which influences cellular migration by inhibiting organization of the actin-cytoskeleton. Treatment of acute stroke presently involves use of rt-PA and/or endovascular treatment with thrombectomy, both…
ReviewAnimal Study
PMID: 30063858
Expert opinion on biological therapy|2018|Ziegler T, Hinkel R, Kupatt C
INTRODUCTION: The establishment of induced pluripotent stem cells (iPSCs) and cardiomyocytes differentiated from them generated a new platform to study pathophysiological processes and to generate drug screening platforms and iPSC-derived tissues as…
Review
PMID: 30063852
Expert opinion on biological therapy|2018|Renga G et al.
INTRODUCTION: Thymosin β4 (Tβ4) is a thymic hormone with multiple and different intracellular and extracellular activities affecting wound healing, inflammation, fibrosis and tissue regeneration. As the failure to resolve inflammation leads to uncont…
Review
PMID: 30063848